Finanzwire Finanzwire
Basculer en Français
9821 Companies
197095 Keywords
128171 Articles
104822 Press releases
Headlines Articles Press releases Rakovina Therapeutics Inc. Remove
  1. Home
  2. Companies
  3. Rakovina Therapeutics Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/02/2025 at 15:36, 10 months 5 days ago

    Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

    Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
  • PRESS RELEASE

    published on 04/02/2025 at 15:31, 10 months 5 days ago

    Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy

    First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments
    First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price
    Logo of Rakovina Therapeutics Inc.
Accesswire
  • Published on 02/07/2026 at 01:00, 1 day 10 hours ago

    Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium

  • Published on 02/06/2026 at 23:10, 1 day 12 hours ago

    Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.

  • Published on 02/06/2026 at 22:01, 1 day 13 hours ago

    Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan

  • Published on 02/06/2026 at 15:30, 1 day 20 hours ago

    Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland

  • Published on 02/06/2026 at 13:30, 1 day 22 hours ago

    Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE
EQS Group
  • Published on 02/07/2026 at 21:00, 14 hours 32 minutes ago

    Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026

  • Published on 02/07/2026 at 16:35, 18 hours 57 minutes ago

    The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

  • Published on 02/07/2026 at 16:20, 19 hours 12 minutes ago

    NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU

  • Published on 02/06/2026 at 19:25, 1 day 16 hours ago

    Funding Circle Holdings plc: POS-Transaction in Own Shares

  • Published on 02/06/2026 at 17:52, 1 day 17 hours ago

    EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

View all EQS
Les Echos
  • Published on 02/06/2026 at 18:22, 1 day 17 hours ago

    Disclosure of Share Capital and Voting Rights as of January 31, 2026

  • Published on 02/06/2026 at 16:01, 1 day 19 hours ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328

  • Published on 02/05/2026 at 19:24, 2 days 16 hours ago

    Minutes of the Combined General Meeting

  • Published on 02/05/2026 at 18:24, 2 days 17 hours ago

    LNA SANTE : 2025 annual sales

  • Published on 02/05/2026 at 18:06, 2 days 17 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy